To unveil cognitive-nigrostriatal correlations in Parkinson's disease (PD), 30 de novo, drug-naïve PD patients and 15 patients with essential tremor (Controls, CTR) underwent a neuropsychological (NPS) battery and brain SPECT with [I-123]Ioflupane, as a biomarker of nigrostriatal function. Automatic extraction of uptake at caudate and putamen level was conducted through the BasGan software, also allowing partial volume effect correction. Because of the multicollinearity among neuropsychological tests and among SPECT variables, factor analysis was applied to 16 neuropsychological scores; moreover, the four SPECT variables were merged into a mean SPECT value (mSPECT). Factor analysis identified four NPS factors: a dys-executive (NPS-EX), a visuospatial (NPS-VS), a verbal memory (NPS-VM), and a ''mixed'' (NPD-MIX) factor. In PD group, there were inverse correlations between UPDRS-III score and both NPS-VS (P < 0.01) and mSPECT (P < 0.05), and a direct correlation between mSPECT and NPS-EX (P < 0.05). Post hoc analysis showed a direct correlation between NPS-EX and caudate uptake in both hemispheres (P < 0.05). Moreover, inverse correlations were found between UPDRS-III and, respectively, putamen uptake in the less affected hemisphere (P < 0.01), and putamen and caudate uptake in the more affected hemisphere (P < 0.05). In CTR, no correlation was found between mSPECT and either NPS or GDS values. Nigro-caudate function affects executive capabilities in PD but not in CTR, which appears to be unrelated to the disease motor severity at its onset. Instead, PD motor severity is related to nigro-putaminal impairment and visuospatial dysfunction. The role of these data as predictive features of cognitive decline and eventually dementia remains to be established in longitudinal studies.2010 Movement Disorder Society Key words: Parkinson's disease; cognitive function; DAT uptake; SPECT; nigrostriatal functionThe relationship between nigrostriatal and cognitive impairment in Parkinson's disease (PD) is a key question to understand the mechanisms leading to cognitive dysfunction. Since nigrostriatal degeneration and consequent dopamine depletion is the main pathological finding of PD, this has been the first candidate to explain cognitive impairment. 1,2 The functional connections between basal ganglia and frontal cortex, together with the dys-executive nature of the early cognitive impairment in PD, would suggest a role of dopamine nigrostriatal dysfunction in PD-related cognitive deficit. 3 Evidence for this hypothesis was provided by the finding that cellular loss in medial substantia nigra correlated with dementia, even after accounting for amyloid cortical burden. 4 However, the striato-frontal pathways mainly involves the caudate nucleus, which is relatively less affected by nigrostriatal disconnection. In fact, the most severe cellular loss is found in the ventrolateral nigra, which innervates dorsolateral putamen, whereas the medioventral and dorsal parts of the nigra, innervating the caudate body and head,